Evidence map›Paper›PMID 41393250›Full record

ArticleJournal of arrhythmia2025

Reduced Left Atrial Appendage Flow Velocity as a Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation.

Shintaro Yamagami, Satoshi Shizuta, Munekazu Tanaka, Shushi Nishiwaki, Takanori Aizawa, Akihiro Komasa, Takashi Yoshizawa, Tetsuma Kawaji, Chihiro Ota, Naoaki Onishi and 11 more

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Shintaro YamagamiDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0003-3192-4639
Satoshi ShizutaDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0003-4587-9031
Munekazu TanakaDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Shushi NishiwakiDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0002-0180-9173
Takanori AizawaDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Akihiro KomasaDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Takashi YoshizawaDepartment of Cardiovascular Medicine Kyoto Medical Center Kyoto Japan.
Tetsuma KawajiDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0001-9929-902X
Chihiro OtaDepartment of Cardiovascular Medicine, Faculty of Medicine University of Tsukuba Tsukuba Japan.
Naoaki OnishiDepartment of Cardiovascular Medicine Osaka Red-Cross Hospital Osaka Japan.
Yasuhiro SasakiDepartment of Cardiovascular Medicine Kobe City Medical Center General Hospital Kobe Japan.ORCID https://orcid.org/0000-0001-7039-4250
Mitsuhiko YahataDepartment of Cardiovascular Medicine Shizuoka General Hospital Shizuoka Japan.
Kentaro NakaiDepartment of Cardiovascular Medicine Hoshigaoka Medical Center Hirakata Japan.
Mamoru HayanoDepartment of Cardiovascular Medicine Kansai Electric Power Hospital Osaka Japan.
Tetsushi NakaoDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Koji HanazawaDepartment of Cardiovascular Medicine Nishinomiya Watanabe Hospital Nishinomiya Japan.
Koji GotoDepartment of Cardiovascular Medicine Fukaya Red Cross Hospital Fukaya Japan.
Takahiro DoiDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Toshihiro TamuraDepartment of Cardiology Tenri Hospital Tenri Japan.
Koh OnoDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.
Takeshi KimuraDepartment of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Reduced left atrial appendage flow velocity (LAAFV) on transesophageal echocardiography (TEE) is recognized as a predictor of thromboembolic events (TEs) in patients with atrial fibrillation (AF). However, its long-term prognostic value following AF ablation remains unclear. Methods and Results: We retrospectively evaluated 1521 patients undergoing AF ablation who underwent preprocedural TEE. Patients were categorized into two groups based on LAAFV: reduced (≤ 21.4 cm/s, Conclusions: Reduced preprocedural LAAFV is associated with adverse long-term clinical outcomes after AF ablation, including a significantly increased risk of thromboembolic events.

Indexed as

atrial fibrillationcatheter ablationleft atrial appendage flow velocitythromboembolism

Identifiers

PMID41393250
PMCPMC12695476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.